Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis
Title:
Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis
Author:
Gomez-Veiga, Francisco Szmulewitz, Russell Z. Holzbeierlein, Jeffrey Azad, Arun A. Iguchi, Taro Villers, Arnauld Alcaraz, Antonio Alekseev, Boris Shore, Neal D. Rosbrook, Brad Zohren, Fabian Ma, Jie Haas, Gabriel P. Stenzl, Arnulf Armstrong, Andrew J.